Related Experiment Video
Updated: Feb 9, 2026

Surface Properties of Synthesized Nanoporous Carbon and Silica Matrices
Published on: March 27, 2019
Celastrol as a pentacyclic triterpenoid with chemopreventive properties
Priya Yadav1, Vishal Jaswal2, Ajay Sharma2
1Department of Biotechnology, Maharishi Markandeshwar University, Mullana-Ambala, Haryana 133207, India.
Abstract:
Celastrol is a highly investigated anticancer moiety. It is a pentacyclic triterpenoid, isolated several decades ago with promising role in chemoprevention. Celastrol has been found to target multiple proinflammatory, angiogenic and metastatic proteins. Inhibition of these targets results in significant reduction of cancer growth, survival and metastasis. This review summarizes the varied molecular targets of celastrol along with insight into the various recently published clinical, preclinical and industrial patents (2011-2017).
Insights
Celastrol, a pentacyclic triterpenoid, shows anticancer potential by targeting multiple proteins involved in inflammation, angiogenesis, and metastasis. This review covers its molecular targets and recent patents (2011-2017).
Area of Science:
- Natural Products Chemistry
- Cancer Biology
- Pharmacology
Background:
- Celastrol is a pentacyclic triterpenoid with a long history of investigation for its therapeutic potential.
- It has demonstrated promising chemopreventive properties.
- Celastrol acts on multiple cellular pathways relevant to cancer development.
Purpose of the Study:
- To review the diverse molecular targets of Celastrol.
- To provide insights into recent (2011-2017) clinical, preclinical, and industrial patents related to Celastrol.
- To consolidate current knowledge on Celastrol's anticancer mechanisms.
Main Methods:
- Literature review of scientific publications.
- Analysis of patent databases (clinical, preclinical, industrial) from 2011-2017.
- Synthesis of information on Celastrol's molecular targets and therapeutic applications.
Main Results:
- Celastrol targets multiple proteins implicated in inflammation, angiogenesis, and metastasis.
- Inhibition of these targets leads to reduced cancer growth, survival, and metastasis.
- A significant number of patents highlight ongoing research and development in Celastrol-based cancer therapies.
Conclusions:
- Celastrol is a multifaceted anticancer agent with broad molecular targeting capabilities.
- Recent patents underscore the continued interest and progress in leveraging Celastrol for cancer treatment.
- Further research into Celastrol's mechanisms and clinical applications is warranted.
Related Concept Videos
Physical and Chemical Properties of Matter
Properties of Transition Metals
General Properties of Solutions
Convolution Properties I
The commutative property reveals that the input and the impulse response of an LTI (Linear Time-Invariant) system can be interchanged without affecting the output:
Properties of DTFT II
The frequency differentiation property is illustrated by considering a DTFT pair and differentiating both sides with respect to ω.
Properties of the z-Transform I

